LIFEVANTAGE CORP Inventory Recall Expense
LIFEVANTAGE CORP (LFVN) reported Inventory Recall Expense of $0 for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryRecallExpense · last filed 2015-09-01
- LIFEVANTAGE CORP inventory recall expense for the quarter ending 2014-06-30 was $0.00.
- LIFEVANTAGE CORP inventory recall expense for the quarter ending 2014-03-31 was $0.00.
- LIFEVANTAGE CORP inventory recall expense for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP inventory recall expense for the quarter ending 2013-06-30 was -$620.00K.
- LIFEVANTAGE CORP inventory recall expense for fiscal 2015 was $0.00.
- LIFEVANTAGE CORP inventory recall expense for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- LIFEVANTAGE CORP inventory recall expense for fiscal 2013 was $4.80M.
- LIFEVANTAGE CORP inventory recall expense for fiscal 2012 was $0.00.
| Period end | Inventory Recall Expense 3 month | Inventory Recall Expense 6 month | Inventory Recall Expense 9 month | Inventory Recall Expense 12 month |
|---|---|---|---|---|
| 2015-06-30 | $0.00 10-K · filed 2015-09-01 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | $0.00 derived: sum of 2 quarters · filed 2015-09-01 | $0.00 derived: sum of 3 quarters · filed 2015-09-01 | $0.00 10-K · filed 2015-09-01 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-06 | $0.00 derived: sum of 2 quarters · filed 2014-05-06 | $0.00 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-06 | $0.00 10-Q · filed 2014-02-06 | ||
| 2013-06-30 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | -$1.08M derived: sum of 2 quarters · filed 2015-09-01 | $4.80M derived: sum of 3 quarters · filed 2015-09-01 | $4.80M 10-K · filed 2015-09-01 |
| 2013-03-31 | -$461.00K 10-Q · filed 2014-05-06 | $5.42M derived: sum of 2 quarters · filed 2014-05-06 | $5.42M 10-Q · filed 2014-05-06 | |
| 2012-12-31 | $5.88M 10-Q · filed 2014-02-06 | $5.88M 10-Q · filed 2014-02-06 | ||
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-10 | $0.00 derived: sum of 2 quarters · filed 2014-09-10 | $0.00 10-K · filed 2014-09-10 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 10-Q · filed 2013-05-09 | ||
| 2011-06-30 | $0.00 10-K · filed 2013-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |